NCT02816684

Brief Summary

Among children, social anxiety is a common, severe and chronic disorder. Social Effectiveness Therapy for Children (SET-C) is an empirically supported treatment with significant potential to impact the lives of children with this severe and chronic disorder. The proposed Pegasys-VR™ system will distinctly enhance its utility, as it will allow dissemination to a broad variety of clinical settings including schools as well as traditional outpatient clinics. Its use for the treatment of social skills deficits will offer a superior solution for mental health personnel, solving many of the resource and logistic barriers that they currently face. The final product will address cost and practical issues by disseminating an empirically-supported treatment that was rigorously built and tested. Using VE will make the traditional social skills therapy programs program cost-effective and patient-centric, allowing even clinicians with little background/training in behavior therapy to have tools not typically available to them.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

June 20, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 28, 2016

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

October 19, 2018

Status Verified

October 1, 2018

Enrollment Period

2.2 years

First QC Date

June 20, 2016

Last Update Submit

October 18, 2018

Conditions

Keywords

phobic disordersanxiety disorders

Outcome Measures

Primary Outcomes (1)

  • Social Phobia and Anxiety Inventory for Children

    self-report measure of social anxiety disorder in children

    Change from baseline at 12 weeks

Secondary Outcomes (5)

  • Diagnosis of Social Anxiety Disorder

    12 weeks

  • Child Behavior Checklist

    Change from baseline at 12 weeks

  • Child Global Assessment of Functioning

    change from baseline at 12 weeks

  • Clinical Global Improvement Scale

    change from baseline at 12 weeks

  • Behavioral Assessment

    change from baseline at 12 weeks

Study Arms (2)

SET-C

ACTIVE COMPARATOR

Social Effectiveness Therapy for Children (SET-C; Beidel et al., 2000) includes social skills training, peer generalization experiences, and in vivo exposure.

Behavioral: Social Effectiveness Therapy for Children

Pegasys-VR

EXPERIMENTAL

SET-C SST and individual exposure sessions are the same as the active comparator. Peer generalization sessions are replaced by a virtual environment, known as Pegasys School. children engage with artificially intelligent avatars throughout the school.

Behavioral: Pegasys-VR

Interventions

Pegasys-VRBEHAVIORAL

Pegasys-VR uses artificially intelligent avatars and serious game technology to assist children in the acquisition and use of social skills.

Pegasys-VR

Group social skills training, peer generalization sessions, individual exposure therapy

SET-C

Eligibility Criteria

Age7 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosis of social anxiety disorder

You may not qualify if:

  • an IQ \< 85 and/or the presence of comorbid conduct disorder, bipolar disorder, severe depression, suicidal ideation, ADHD, developmental disorders or psychotic disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCF RESTORES, University of Central Florida

Orlando, Florida, 32816, United States

Location

MeSH Terms

Conditions

Anxiety DisordersPhobic Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Deborah C Beidel, Ph.D.

    University of Central Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2016

First Posted

June 28, 2016

Study Start

June 1, 2016

Primary Completion

August 1, 2018

Study Completion

August 1, 2018

Last Updated

October 19, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share

Locations